(SUZ) Suzano Papel e Celulose - Overview
Stock: Pulp, Paper, Biofuel, Textiles
| Risk 5d forecast | |
|---|---|
| Volatility | 28.0% |
| Relative Tail Risk | -12.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.26 |
| Alpha | -6.34 |
| Character TTM | |
|---|---|
| Beta | 0.695 |
| Beta Downside | 0.785 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.01% |
| CAGR/Max DD | 0.32 |
EPS (Earnings per Share)
Revenue
Description: SUZ Suzano Papel e Celulose March 04, 2026
Suzano S.A. is a Brazilian company producing pulp and paper products globally. Its operations are divided into Pulp, and Paper and Consumer Goods segments. The company produces various papers (printing, writing, tissue) and pulps (market, fluff).
Beyond its core business, Suzano engages in diversified activities. These include biofuel research, port terminal operations, and power generation. The company also invests in biotechnology, lignin research, and the development of cellulose-based fibers and textiles. The paper products sector is cyclical, influenced by global demand for packaging and printing materials. The pulp industry is capital-intensive, requiring significant investment in forestry and processing facilities.
Understanding the companys full scope and market position is crucial for investors. For a deeper dive into financial metrics and peer comparisons, consider exploring ValueRay.
Headlines to watch out for
- Global pulp prices dictate Cellulose segment revenue
- Brazilian Real exchange rate impacts export competitiveness
- Paper demand fluctuations affect sales volume
- Timberland acquisition costs influence operational expenses
- Environmental regulations pose compliance risks
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 13.42b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.88 > 1.0 |
| NWC/Revenue: 59.78% < 20% (prev 37.35%; Δ 22.43% < -1%) |
| CFO/TA 0.11 > 3% & CFO 18.22b > Net Income 13.42b |
| Net Debt (91.05b) to EBITDA (30.04b): 3.03 < 3 |
| Current Ratio: 3.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.24b) vs 12m ago -0.25% < -2% |
| Gross Margin: 32.06% > 18% (prev 0.42%; Δ 3.16k% > 0.5%) |
| Asset Turnover: 30.15% > 50% (prev 28.57%; Δ 1.58% > 0%) |
| Interest Coverage Ratio: 2.91 > 6 (EBITDA TTM 30.04b / Interest Expense TTM 6.50b) |
Altman Z'' 2.88
| A: 0.18 (Total Current Assets 43.85b - Total Current Liabilities 13.77b) / Total Assets 167.85b |
| B: 0.12 (Retained Earnings 20.20b / Total Assets 167.85b) |
| C: 0.11 (EBIT TTM 18.90b / Avg Total Assets 166.89b) |
| D: 0.53 (Book Value of Equity 65.50b / Total Liabilities 123.92b) |
| Altman-Z'' Score: 2.88 = A |
Beneish M -3.15
| DSRI: 0.82 (Receivables 8.96b/10.24b, Revenue 50.32b/47.40b) |
| GMI: 1.32 (GM 32.06% / 42.19%) |
| AQI: 0.52 (AQ_t 0.17 / AQ_t-1 0.32) |
| SGI: 1.06 (Revenue 50.32b / 47.40b) |
| TATA: -0.03 (NI 13.42b - CFO 18.22b) / TA 167.85b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of SUZ shares?
Over the past week, the price has changed by -5.42%, over one month by -7.75%, over three months by +15.04% and over the past year by +7.73%.
Is SUZ a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SUZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.6 | 34.6% |
| Analysts Target Price | 13.6 | 34.6% |
SUZ Fundamental Data Overview March 16, 2026
P/E Forward = 8.6133
P/S = 0.2469
P/B = 1.4672
Revenue TTM = 50.32b USD
EBIT TTM = 18.90b USD
EBITDA TTM = 30.04b USD
Long Term Debt = 91.80b USD (from longTermDebt, last quarter)
Short Term Debt = 2.34b USD (from shortTermDebt, last quarter)
Debt = 106.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 91.05b USD (from netDebt column, last quarter)
Enterprise Value = 113.30b USD (12.37b + Debt 106.22b - CCE 5.30b)
Interest Coverage Ratio = 2.91 (Ebit TTM 18.90b / Interest Expense TTM 6.50b)
EV/FCF = 20.11x (Enterprise Value 113.30b / FCF TTM 5.63b)
FCF Yield = 4.97% (FCF TTM 5.63b / Enterprise Value 113.30b)
FCF Margin = 11.20% (FCF TTM 5.63b / Revenue TTM 50.32b)
Net Margin = 26.67% (Net Income TTM 13.42b / Revenue TTM 50.32b)
Gross Margin = 32.06% ((Revenue TTM 50.32b - Cost of Revenue TTM 34.18b) / Revenue TTM)
Gross Margin QoQ = 29.44% (prev 30.44%)
Tobins Q-Ratio = 0.67 (Enterprise Value 113.30b / Total Assets 167.85b)
Interest Expense / Debt = 1.62% (Interest Expense 1.72b / Debt 106.22b)
Taxrate = 13.63% (18.6m / 136.5m)
NOPAT = 16.32b (EBIT 18.90b * (1 - 13.63%))
Current Ratio = 3.19 (Total Current Assets 43.85b / Total Current Liabilities 13.77b)
Debt / Equity = 2.43 (Debt 106.22b / totalStockholderEquity, last quarter 43.79b)
Debt / EBITDA = 3.03 (Net Debt 91.05b / EBITDA 30.04b)
Debt / FCF = 16.16 (Net Debt 91.05b / FCF TTM 5.63b)
Total Stockholder Equity = 42.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.04% (Net Income 13.42b / Total Assets 167.85b)
RoE = 31.49% (Net Income TTM 13.42b / Total Stockholder Equity 42.61b)
RoCE = 14.06% (EBIT 18.90b / Capital Employed (Equity 42.61b + L.T.Debt 91.80b))
RoIC = 12.35% (NOPAT 16.32b / Invested Capital 132.10b)
WACC = 2.13% (E(12.37b)/V(118.60b) * Re(8.47%) + D(106.22b)/V(118.60b) * Rd(1.62%) * (1-Tc(0.14)))
Discount Rate = 8.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.97%
[DCF] Terminal Value 80.82% ; FCFF base≈5.02b ; Y1≈3.30b ; Y5≈1.50b
[DCF] Fair Price = N/A (negative equity: EV 47.91b - Net Debt 91.05b = -43.14b; debt exceeds intrinsic value)
EPS Correlation: -14.08 | EPS CAGR: -21.36% | SUE: -0.03 | # QB: 0
Revenue Correlation: 27.84 | Revenue CAGR: 8.68% | SUE: -0.02 | # QB: 0
EPS current Year (2026-12-31): EPS=1.19 | Chg7d=+0.036 | Chg30d=+0.303 | Revisions Net=+1 | Growth EPS=-42.8% | Growth Revenue=+11.7%